Stoke Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of STOK for the last quarter is 2.80 M USD, and it's 15.30% lower compared to the previous quarter. The net income of Q4 23 is -26.96 M USD.